SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $M... See more
Jan, 11, 2023
$SAVA I'm loving the move, can't wait for ... See more
ARDX
Ardelyx Inc
23.58%
$3.35 - $4.14
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
This should have no problem getting approved.
Mar, 21, 2023
This is 100% normal and part of the growth of a st... See more
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.
Jan, 11, 2023
$SAVA I'm loving the move, can't wait for the approval, buy out at $500, sell at $1200.
Jan, 7, 2023
$SAVA diseases like Alzheimer’s will have more Than 1 drug approved for the indication.. being first is great,
Jan, 6, 2023
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
Jan, 6, 2023
$SAVA biib up 3.00 on approval sava will go up 100+ on approval
Jan, 6, 2023
no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !
Nov, 6, 2022
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
Oct, 20, 2022
This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.
Oct, 14, 2022
Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!
Mar, 13, 2023
gets a drug approved and immediately rewards shareholders!!!
Feb, 22, 2023
$PRVB 8.60 to 8.80 has been good support since approval.
Feb, 18, 2023
If that gets approved its 10.000 times better than Provention Bio.
Feb, 6, 2023
Great to see the FDA approval, as well as $SNY commitment.
Nov, 25, 2022
$PRVB While reaching this milestone of approval has been inspirational, it is now the aspirational goal of population screening which is at the forefront.
Nov, 22, 2022
It works, there is a need for it, there is insurance buy in on it, there is a global sales team, there is further label expansion and approvals in the future, and there are additional drugs in the pipeline from this company that show the same promise.
Nov, 21, 2022
PRVB is in a MUCH better financial situation now with FDA approval giving them a multi-billion USD asset (Teplizumab) which they can get conventional financing from A BANK!!
Nov, 21, 2022
It's APPROVED !!
Nov, 18, 2022
$PRVB Interesting they received approval which is good.
Nov, 18, 2022
$PRVB good that they have got an approval.
Mar, 21, 2023
This should have no problem getting approved.
Mar, 21, 2023
This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.
Mar, 20, 2023
Better than money in the bank with soon resubmission and approval 2-6 months later!
Mar, 16, 2023
Going to be an absolute banger when Xphozah gets approved.
Mar, 4, 2023
And this is just a beginning, FDA approval will take it to the skies.
Feb, 3, 2023
Perfect setup for Tenapanor approval.
Feb, 3, 2023
$AKBA within 3 to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..
Jan, 30, 2023
$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.
Jan, 30, 2023
$ARDX when we get fda approval will be shining